Adverse Drug Reactions
Studies from Dalhousie University, Clinical Trials Research Center provide new data on adverse drug reactions
Published in Drug Week, February 16th, 2007
A new study, "Phase 1 first-in-human studies of the reactogenicity and immunogenicity of a recombinant meningococcal NspA vaccine in healthy adults," is now available. According to a study from Halifax, Canada, "Neisserial surface protein A (NspA) is a highly conserved, surface-exposed outer membrane protein of Neisseria meningitidis that has been shown to induce a bactericidal immune response in animals against all pathogenic Neisserial serogroups. Healthy 18-50-year-old adults were assigned to receive, in a dose escalating manner, 3 doses of 1 of 5 formulations of an experimental, unfolded, recombinant NspA (rNspA) vaccine or placebo, or 1 dose of commercially available...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2007-02-16)
More Articles from Drug Week
- Cancer Therapy
MGI PHARMA reports publication of phase III data for Saforis Powder in UpTec - Depression
Novartis/Servier drug expected to achieve blockbuster status in antidepressant market - Market Analysis
Cutting Edge Information reports 42% of pharma firms outsource phase IV research - Alzheimer Disease Therapy
Saitama Medical University, Department of Pharmacology details research in Alzheimer disease therapy - Angiotensins
Research from Monash University has provided new information about angiotensins - Angiotensins
Research from University of Ioannina, Division of Cardiology has provided new information about angiotensins - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
